TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ribozyme Sweden AB
Closing information (x1000 SEK)
Closing information | 2023/08 | 2022/08 | 2021/08 |
Turnover |
30
|
18
|
0 |
Financial expenses |
18
![]() |
18
![]() |
18 |
Earnings before taxes |
-10
|
-20
|
-33 |
EBITDA |
8
|
-2
|
-14 |
Total assets |
1,476
|
1,468
|
1,460 |
Current assets |
57
|
49
|
41 |
Current liabilities |
910
|
892
|
864 |
Equity capital |
566
|
576
|
596 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Solvency |
38.3%
|
39.2%
|
40.8% |
Turnover per employee |
30
|
18
|
0 |
Profit as a percentage of turnover |
-33.3%
|
-111.1% | |
Return on assets (ROA) |
0.5%
|
-0.1%
|
-1.0% |
Current ratio |
6.3%
|
5.5%
|
4.7% |
Return on equity (ROE) |
-1.8%
|
-3.5%
|
-5.5% |
Change turnover |
12
|
18
|
0 |
Change turnover % | 67% | ||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/08 | 2022/08 | 2021/08 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.